Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18432742 | 0.89 | TAS1R3 (0.33) | TSHRSMN1; SMN2NR3C1 | |
| SCHEMBL16475482 | 0.89 | NR3C1 (0.32) | TSHRSMN1; SMN2NR3C1 | |
| SCHEMBL24270802 | 0.86 | TSHR (0.33) | TSHRSMN1; SMN2 | |
| SCHEMBL22642564 | 0.84 | TSHR (0.32) | TSHRSMN1; SMN2 | |
| SCHEMBL20047250 | 0.83 | RECQL (0.30) | RECQL | |
| SCHEMBL19105207 | 0.83 | NR3C1 (0.35) | TSHRSMN1; SMN2NR3C1CA1CA2 | |
| SCHEMBL13917867 | 0.83 | NR3C1 (0.35) | TSHRSMN1; SMN2NR3C1CA1CA2 | |
| SCHEMBL319016 | 0.82 | CA1 (0.39) | NR3C1CA1CA2 | |
| SCHEMBL1401784 | 0.81 | TSHR (0.33) | TSHRSMN1; SMN2NR3C1 | |
| SCHEMBL21389209 | 0.80 | DGAT1 (0.34) | TSHRSMN1; SMN2NR3C1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3029 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121874958-B | Antibacterial thermal insulation fiber based on thermal insulation material and preparation method thereof | BOSIDENG DOWN WEAR Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| EP-3811977-B1 | METHOD FOR SYNTHESIS OF REACTIVE CONJUGATE CLUSTERS | IONIS PHARMACEUTICALS INC (US) | 2025-12-03 | — | — | EP | claimed |
| CN-119638592-A | Preparation method of cable-marlutide side chain | 苏州昊帆生物股份有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119039583-B | Side-chain base biodegradable polyester amide with stereocomplex crystallization performance and enzymatic preparation method thereof | 浙江农林大学 | 2025-03-11 | — | — | CN | claimed |
| CN-119108555-A | Sodium-electricity coal-based hard carbon negative electrode material and preparation method thereof | 洛阳新能源科技发展集团有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-119039583-A | Side-chain base biodegradable polyester amide with stereocomplex crystallization performance and enzymatic preparation method thereof | 浙江农林大学 | 2024-11-29 | — | — | CN | claimed |
| CN-118516856-A | Transparent conductive shielding film with high flexibility and preparation method thereof | 深圳市海普睿能科技有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-118290730-A | Cyclopropene cationic polymer, and preparation method and application thereof | 华南理工大学 | 2024-07-05 | — | — | CN | claimed |
| CN-118271335-A | Accurate positioning method for abasic site in genomic DNA | 北京大学 | 2024-07-02 | — | — | CN | claimed |
| US-20240150390-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-05-09 | — | — | US | claimed |
| US-20040225097-A1 | NOVEL PREPARATION METHOD OF PEG-MALEIMIDE DERIVATIVES | SUNBIO INC. (KR) | 2004-11-11 | — | — | US | claimed |
| US-20040115165-A1 | Bifunctional polyethylene glycol derivatives | SUN BIO, INC. | 2004-06-17 | — | — | US | claimed |
| US-20040010029-A1 | Indole derivatives as interleukin -4 gene expression inhibitors | AVENTIS PHARMACEUTICALS INC. | 2004-01-15 | — | — | US | claimed |
| WO-2003091215-A1 | 3-SUBSTITUTED AMINO-1H-INDOLE-2-CARBOXYLIC ACID AND 3-SUBSTITUTED AMINO-BENZO’ B! THIOPHENE-2-CARBOXYLIC ACID DERIVATIVES AS INTERIEUKIN-4 GENE EXPRESSION INHIBITORS | AVENTIS PHARMACEUTICALS INC. (US) | 2003-11-06 | — | — | WO | claimed |
| US-6562944-B1 | Generation of preferential halogen compound; obtain carboxylic acid mixture, incubabte with halogenated compound, recover by-product | LEXICON PHARMACEUTICALS | 2003-05-13 | — | — | US | claimed |
| EP-0749446-B1 | HIGHLY REACTIVE ESTERS OF CARBOXY POLYSACCHARIDES AND NOVEL CARBOXY POLYSACCHARIDES DERIVED THEREFROM | FIDIA ADVANCED BIOPOLYMERS SRL (IT) | 1999-11-24 | — | — | EP | claimed |
| US-5856299-A | ESTERIFICATION WITH ALCOHOL | FIDIA ADVANCED BIOPOLYMERS S.R.L. (IT) | 1999-01-05 | — | — | US | claimed |
| EP-0749446-A1 | HIGHLY REACTIVE ESTERS OF CARBOXY POLYSACCHARIDES AND NOVEL CARBOXY POLYSACCHARIDES DERIVED THEREFROM | FIDIA ADVANCED BIOPOLYMERS S.R.L. (IT) | 1996-12-27 | — | — | EP | claimed |
| WO-1995024429-A1 | HIGHLY REACTIVE ESTERS OF CARBOXY POLYSACCHARIDES AND NOVEL CARBOXY POLYSACCHARIDES DERIVED THEREFROM | FIDIA ADVANCED BIOPOLYMERS S.R.L. (IT) | 1995-09-14 | — | — | WO | claimed |
| US-4978744-A | Synthesis of dolastatin 10 | ARIZONA BOARD OF REGENTS (US) | 1990-12-18 | — | — | US | claimed |